CareCloud, Inc. CCLD
2.02 USD -0.30 (-12.93%)
Regular-session close
2.16 +0.14 +6.93%
After hours · Nov 20, 5:15 PM ET
1.88 Day range 2.27
1.71 52-week range 3.81
- YTD
- -30.82%
- 1 year
- -29.12%
News
defenseworld.net Head-To-Head Survey: OptimizeRx (NASDAQ:OPRX) vs. CareCloud (NASDAQ:CCLD) CareCloud (NASDAQ: CCLD - Get Free Report) and OptimizeRx (NASDAQ: OPRX - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two…
globenewswire.com CareCloud Accelerates AI-Powered Growth with Over 40% Reduction in Claim Denials and Multiple New RCM Wins New RCM relationships demonstrate CareCloud's strategy to convert acquisitions, AI innovation and existing customer relationships into recurring revenue opportunities.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session. ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of…
benzinga.com CareCloud Q3 2026 Earnings Call Transcript CareCloud (NASDAQ:CCLD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…benzinga.com CareCloud Q3 Adj. EPS $0.14 Beats $0.12 Estimate, Sales $33.725M Beat $33.492M Estimate CareCloud (NASDAQ:CCLD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.12 by 16.67 percent. This is a 40 percent increase over earnings of $0.10 per…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers ADMA Biologics (NASDAQ:ADMA) shares rose 19.6% to $12.53 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3…benzinga.com CareCloud Affirms FY2026 GAAP EPS Guidance of $0.20-$0.23 vs $0.18 Est; Affirms FY2026 Sales Guidance of $128.000M-$132.000M vs $130.468M Est CareCloud (NASDAQ:CCLD) affirms FY2026 GAAP EPS guidance from $0.20-$0.23 to $0.20-$0.23 vs $0.18 analyst estimate. Affirms FY2026 sales outlook from $128.000 million-$132.000 million to $128.000…
